At the news
? NEUTRALIMPACT 3/10 8-K filed Nov 16, 2026 at 06:01 ET
DataMEDS AI, Inc. entered into an ATM sales agreement with Dawson James Securities to sell up to $10,003,649 of its common stock from time to time in at-the-market offerings. The company is not obligated to sell any shares, and the agreement provides a 3.0% commission to the sales agent. This establishes a potential equity dilution facility but no shares have been sold yet.
- DataMEDS AI, Inc. entered into an ATM sales agreement with Dawson James Securities on November 16, 2026
- Maximum offering amount is $10,003,649 of common stock
- Sales agent receives 3.0% commission on gross proceeds from each sale
- Company is not obligated to sell any shares under the agreement
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access